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ABSTRACT
Renal injury is reported to have a high mortality rate. Additionally, there are several limitations to current
conventional treatments that are used to manage it. This study evaluated the protective effect of hesperidin
against ischemia/reperfusion (I/R)-induced kidney injury in rats. Renal injury was induced by generating I/
R in kidney tissues. Rats were then treated with hesperidin at a dose of 10 or 20 mg/kg intravenously 1 day
after surgery for a period of 14 days. The effect of hesperidin on renal function, serum mediators of
inflammation, and levels of oxidative stress in renal tissues were observed in rat kidney tissues after I/R-
induced kidney injury. Moreover, protein expression and mRNA expression in kidney tissues were
determined using Western blotting and RT-PCR. Hematoxylin and eosin (H&E) staining was done for
histopathological observation of kidney tissues. The data suggest that the levels of blood urea nitrogen
(BUN) and creatinine in the serum of hesperidin-treated rats were lower than in the I/R group. Treatment
with hesperidin also ameliorated the altered level of inflammatory mediators and oxidative stress in I/R-
induced renal-injured rats. The expression of p-IkBa, caspase-3, NF-kB p65, Toll-like receptor 4 (TLR-4)
protein, TLR-4 mRNA, and inducible nitric oxide synthase (iNOS) was significantly reduced in the renal
tissues of hesperidin-treated rats. Histopathological findings also revealed that treatment with hesperidin
attenuated the renal injury in I/R kidney-injured rats. In conclusion, our results suggest that hesperidin
protects against renal injury induced by I/R by involving TLR-4/NF-kB/iNOS signaling.
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Acute renal injury (ARI) is a disorder with a high mortality rate; if a patient survives it, he/she is
at increased risk of developing chronic renal failure [8]. In developing countries, 1% of total
health expenditure costs are used for the treatment of diseases like ARI and its associated
complications [2]. ARI patients are commonly reported to have decreased renal function, to
suffer from ischemic disorders and sepsis, and to require renal transplantation [3]. Several
factors are involved in the pathogenesis of ischemia/reperfusion (I/R)-induced renal injury.
These include a dysfunction in energy metabolism, apoptosis, calcium overload, inflammatory
mediators, and free radicals [12]. Conventional therapies available for the management of ARI
have several limitations. In the last few decades, alternative medicine has proven to have a
beneficial effect against the disease.
Molecules from natural sources are reported to be useful in the management of several
disorders as alternative medicines. Hesperidin is a flavonoid that is isolated from plants
belonging to the Lamiaceae and Betulaceae family [9]. Hesperidin has been shown to attenuate
apoptosis, hypotension, oxidative stress, and inflammation [16, 21, 22]. It also protects against
neuronal injury by ameliorating oxidative stress and inflammation [16]. Moreover, hesperidin
has antimicrobial, anticancer, antiarthritic, anti-hypercholesterolemic, and anti-atherogenic
activity [1, 10, 14]. Furthermore, hesperidin attenuates pancreatitis by inhibiting the TLR4/
IRAK1/NF-kB pathway [11]. Thus, this investigation evaluated the beneficial effect of hesperidin
against I/R-induced ARI in rats.MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats that weighed 200–230 g each were purchased from Shanghai Medical
College (Shanghai, China). Standard guidelines (humidity: 60 ± 5%; temperature: 24 ± 3 8C)
were used to maintain the animals on a 12-h light/dark cycle. All study protocols were approved
by the Institutional Animal Care and Use Committee of the Affiliated Hospital of Jining Medical
University, Jining, China (IACUC/AH-JMU/2017–09).
Chemicals
Hesperidin was procured from Sigma Aldrich Ltd., USA and Biochemical estimation kits were
purchased from Runyu Biotechnology Co., Shanghai, China. ELISA kits used for the determi-
nation of the level of inflammatory mediators and parameters of oxidative stress were procured
from Runyu Biotechnology Co., Shanghai, China. Antibodies used for the western blot assay
were procured from Abcam, Shanghai, China and Cell Signaling Technology, Denver, Colorado,
USA.
Induction of ARI. All animals were anesthetized using an intraperitoneal injection of ketamine
(75 mg/kg) and dexmedetomidine (0.5 mg/kg). Next, a surgical procedure was performed at a
controlled temperature of 37 ± 0.5 8C by keeping the animal on a thermal heating pad. The left
renal pedicle of the kidney was exposed by cutting the muscle and skin of the left abdomen.
84 Physiology International 107 (2020) 1, 82–91Renal pedicle vessels were then blocked for 45 min using an atraumatic bulldog clamp. Recovery
of blood flow was achieved by removing the clamp. The animals were separated into four
different groups: the control group (sham-operated), the I/R group (underwent I/R surgery and
were treated with saline 1 day after surgery), and the hesperidin 10 and 20 mg/kg groups, which
were treated intravenously with hesperidin at 10 or 20 mg/kg, respectively, 1 day after surgery
for a period of 14 days. Blood was then collected from the retroorbital plexus to examine
biochemical parameters.
Assessment of renal function. Renal function was assessed by measuring the concentration of
serum creatinine, total protein, and blood urea nitrogen (BUN) in the blood of all animals. The
serum levels of creatinine, total protein, and BUN were estimated as per the manufacturer’s
protocol.
Assessment of inflammatory mediators and oxidative stress. Inflammatory mediators were
measured using an ELISA assay. Inflammatory mediators including IL-10, IL-1b, and TNF-a
were estimated in the serum of I/R-induced renal-injured rats by using ELISA kits as per the
manufacturer’s protocol. The levels of malondialdehyde (MDA), reduced glutathione (GSH),
xanthine oxidase (XO) activity, catalase (CAT), and superoxide dismutase (SOD) were also
estimated in renal tissues as per the manufacturer’s protocol. The level of inducible nitric oxide
synthase (iNOS) in renal tissues was determined using an ELISA kit.
Histopathology of renal tissues
All animals were sacrificed and the kidneys of the animals were isolated. A 10% formalin so-
lution was used to fix the kidney tissues, and paraffin was used to embed the tissues. A
microtome was used to section the kidney tissues at a thickness of 4 mm, and the sections were
stained using hematoxylin and eosin (H&E). A light microscope was used to analyze the sec-
tions. A score of 0–4 was used to grade the percentage of necrosis and degeneration using the
following parameters: normal 5 0; <10% 5 1; 10–25% 5 2; 26–75% 5 3; and >75% 5 4.
Western blotting. Kidney tissue homogenates were prepared and centrifuged at 12,000 RPM for
5 min. A total protein extraction kit was used to extract protein from the tissue samples. A
bicinchoninic acid assay was used to determine the concentration of protein. Next, 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis was used to separate the proteins, which were
then transferred to a nitrocellulose membrane by electroblotting. Subsequently, the membrane
was blocked with 5% non-fat milk and incubated in blocking buffer overnight at 4 8C with the
following primary antibodies: anti-phosphorylated IkBa (1:500 dilution), anti-caspase-3 (1:200
dilution), anti-NF-kB p65 (1:500 dilution), anti-TLR-4 (1:500 dilution), and anti-a-tubulin
(1:1000 dilution; loading control). Secondary goat antibodies conjugated to horseradish
peroxidase (HRP) were added to the blocking buffer (1:1,000; non-fat milk) and a chem-
iluminescence kit was used to detect proteins. A Bio-Rad detection system (Hercules, CA, USA)
was used to record and visualize the immunoblots. Protein density was analyzed using ImageJ
software (Bio-Rad, Shanghai, China).
RT-PCR. RNA was isolated from separated spinal cord tissue with TRIzol Reagent (Thermo
Fisher Scientific, Waltham, MA, USA). A RevertAid First Strand cDNA Synthesis Kit (Thermo
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mixed with RT 2 SYBR Green Master Mix (Qiagen, Hilden, Germany) to analyze gene
expression using Quantitative SYBR Green PCR assays (Applied Biosystems, Bedford, MA,
USA). Primers used for the qRt-PCR were as follows: iNOS (forward: 50-GTG GTG ACA AGC
ACA TTT GG-30, reverse: 50-GGC TGG ACT TTT CAC TCT GC-30); TLR4 (forward 50-
CCTCCCCTGTACCCTTCTCACTG-30, reverse 50-ACGGCTACACCATTTTCCATTCC-30);
b-catenin (forward: 50-GTCTTACCTGGACTCTGGAATCC-30, reverse: 50-GGTATCCA-
CATCCTCTTCCTCAG-30).RESULTS
Hesperidin ameliorates the markers of renal injury
The effects of I/R-induced kidney injury in rats were confirmed (Fig. 1A and B). The effect of
hesperidin was determined by estimating the serum concentrations of BUN and creatinine. The
levels of BUN and creatinine were increased up to 63 mmol/L and 346 mmol/L in the serum of
the control and I/R groups, respectively. However, treatment with hesperidin reduced the serum
levels of creatinine (156 mmol/L) and BUN (26 mmol/L) compared to the I/R group.
Hesperidin increases mediators of inflammation
Inflammatory mediators in the serum of rats with I/R-induced kidney injury and hesperidin
treatment were analyzed (Fig. 2). The levels of TNF-a (318 pg/mL), IL-1b (154 pg/mL), and IL-
10 (95 pg/mL) were enhanced in the serum of the I/R group compared to the control group.
There were lower levels of TNF-a and IL-1b (204 and 63 pg/mL, respectively) in the serum of
the hesperidin-treated group compared to the I/R group of rats. Moreover, treatment with
hesperidin increased the serum level of IL-10 (192 pg/mL) unlike in the I/R group.Figure 1. Hesperidin ameliorates the altered concentrations of markers involved in kidney injury caused by
I/R. A: BUN. B: Creatinine. Data are presented as means ± SEM (n 5 10). **P < 0.01 compared to the
control group; ##P < 0.01 compared to the I/R group
Figure 2. Hesperidin ameliorates the altered concentrations of inflammatory mediators in the serum of rats
with I/R-induced kidney injury. Data are presented as means ± SEM (n 5 10). **P < 0.01 compared to the
control group; ##P < 0.01 compared to the I/R group
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The renal level of oxidative stress was determined by estimating parameters of oxidative stress in
homogenates of kidney tissues from I/R-induced kidney-injured rats (Fig. 3A–F). There were
significant (P < 0.01) increases in the levels of MDA, XO activity, and iNOS in the renal tissues
of the I/R group compared to the control group. Moreover, the levels of GSH, SOD activity, and
CAT were significantly (P < 0.01) reduced in the renal tissues of the I/R group compared to the
control group. Treatment with hesperidin attenuated the altered parameters of oxidative stress
in the renal tissues of rats with I/R-induced kidney injury.
Hesperidin improves the histopathology of renal tissues
The histopathology of renal tissues of rats with I/R-induced kidney injury was analyzed using H&E
staining (Fig. 4). Kidney tissues from control rats showed normal morphology. In contrast, kidney
tissues from the I/R group showed leukocyte infiltration, swelling, congestion, hemorrhage, and tu-
bules in the glomeruli. The kidney tissues from hesperidin-treated rats appeared to have normal
morphology (Fig. 4A). The necrosis and degeneration scores were higher in the I/R group compared
to the control group (Fig. 4B). There were significant reductions in the necrosis and degeneration
scores in kidney tissues fromhesperidin-treated rats compared to rats with I/R-induced kidney injury.
Hesperidin ameliorates the expression of the TLR-4/NF-kB pathway
In rats treated with hesperidin, the expression of Toll-like receptor 4 (TLR-4), NF-kB, p-IkBa, and
caspase-3 protein in renal tissues was analyzed (Fig. 5A and B). The expression of TLR-4, NF-kB,
p-IkBa, and caspase-3 protein was higher in the renal tissues of rats with I/R-induced kidney
injury compared to the control group. However, rats treated with hesperidin showed a decrease in
the expression of TLR-4, NF-kB, p-IkBa, and caspase-3 protein compared to the I/R group.
Hesperidin increases the mRNA expression of iNOS and TLR-4
The effect of hesperidin on the TLR-4/iNOS signaling pathway was investigated by measuring
the mRNA expression of TLR-4 and iNOS in the renal tissues of rats with I/R-induced kidney
Figure 3. Hesperidin improves the altered parameters of oxidative stress in renal tissues from rats with I/R-
induced kidney injury. A: Concentration of MDA in the kidney tissue. B: Concentration of GSH in the
kidney tissue. C: Activity of SOD in the kidney tissue. D: Activity of CAT in the kidney tissue. E: Activity of
XO in the kidney tissue. F: Activity of iNOS in the kidney tissue. Data are presented as means ± SEM (n 5
10). **P < 0.01 compared to the control group; ##P < 0.01 compared to the I/R group
Figure 4. Hesperidin ameliorates the histopathological changes in renal tissues of rats with I/R-induced
kidney injury. A: Histopathology of renal tissues as indicated by H&E staining (1003). B: Necrosis and
degeneration scores. Data are presented as means ± SEM (n 5 10). **P < 0.01 compared to the control
group; ##P < 0.01 compared to the I/R group
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Figure 6. Hesperidin improves the altered mRNA expression TLR-4 and iNOS in the renal tissues of rats
with I/R-induced kidney injury. Data are presented as means ± SEM (n 5 10). **P < 0.01 compared to the
control group; ##P < 0.01 compared to the I/R group
Figure 5. Hesperidin ameliorates the altered expression TLR-4, NF-kB, p-IkBa, and caspase-3 protein in
the renal tissues of rats with I/R-induced kidney injury. A: Western blots. B: Expression levels of TLR-4,
NF-kB, p-IkBa, and caspase-3 protein. Data are presented as means ± SEM (n 5 10). **P < 0.01 compared
to the control group; ##P < 0.01 compared to the I/R group
88 Physiology International 107 (2020) 1, 82–91injury (Fig. 6). There was an increase in the mRNA expression of TLR-4 and iNOS in the renal
tissues of the I/R group compared to the control group. However, treatment with hesperidin
decreased the mRNA expression of TLR-4 and iNOS.DISCUSSION
Renal injury is reported to have a high mortality rate, and there are several limitations to current
conventional treatments that are used to manage it [20]. This report evaluated the protective
effect of hesperidin against I/R-induced kidney injury in rats. The effect of hesperidin on renal
function, serum inflammatory mediators, and the level of oxidative stress in renal tissues was
observed in rats with I/R-induced kidney injury. Moreover, protein expression and mRNA
expression in the kidney tissues were determined by Western blotting and RT-PCR, respectively.
Kidney tissues were analyzed using H&E staining for histopathological changes.
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example is I/R, because it disturbs the balance between the antioxidant system and the
production of reactive oxygen species [6]. Oxidative stress leads to cell death via the mito-
chondrial pathway, which includes the necrosis and apoptosis pathways [17]. Oxidative stress
affects molecules such as MDA and GSH, while also altering the activity of several enzymes,
including CAT, SOD, XO, and iNOS [13]. Drugs used for the management of kidney disease
are reported to have strong antioxidant activity [19]. Hesperidin is a natural substance that is
reported to possess strong antioxidant activity [22]. This study also revealed that hesperidin
attenuated the enhanced oxidative stress in the renal tissues of rats with I/R-induced kidney
injury.
Inflammation is a major factor that contributes to the development of renal injury. More-
over, inflammatory mediators like TNF-a and IL-1b are involved in renal injury [4]. It is well
documented that oxidative stress leads to enhanced production of TNF-a and IL-1b, which
further contributes to kidney injury [15]. IL-10 has also been reported to be an anti-inflam-
matory mediator that protects against renal injury [7]. Our data suggest that treatment with
hesperidin significantly reduced the levels of TNF-a and IL-1b while increasing the serum level
of IL-10 compared to rats with I/R-induced kidney injury.
TLR-4 activates the immune system at the site of injured tissues. TLR-4 has also been re-
ported to initiate the production of intrarenal mediators of inflammation. Moreover, TLR-4
enhances the levels of TNF-a and IL-1b in renal injury [23]. The activation of oxidative stress
and NF-kB regulates the further downstream production of cytokines, which contribute to the
development of renal injury [5]. Other investigations have also found that I/R induces renal
injury by altering the TLR-4/NF-kB signaling pathway [18]. Our study shows that treatment
with hesperidin attenuated the alteration of the TLR-4/NF-kB signaling pathway in renal tissues
of rats with I/R-induced kidney injury. Moreover, histopathological analysis revealed that I/R
induces kidney injury by activating apoptosis. Apoptosis is activated by enhancing the activity of
caspase-3 in a downstream cascade. Data from our investigation suggest that hesperidin ame-
liorates apoptosis given that it reduces the activity of caspase-3 in the renal tissues of rats with I/
R-induced renal injury.CONCLUSION
Hesperidin protected against renal injury in rats with I/R-induced kidney injury. It also reduced
the level of inflammatory mediators and oxidative stress in I/R-induced kidney injury and
thereby increased TLR-4/NF-kB/iNOS signaling.
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